Real ChatGPT answer · index seedKvWLLPoTP6QcompleteHealth and wellness · common conditions and symptomscommercial
Evaluate the current clinical consensus on low-dose naltrexone for fibromyalgia and chronic fatigue syndrome treatment protocols.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Evaluate the current clinical consensus on low-dose naltrexone for fibromyalgia and chronic fatigue syndrome treatment protocols.
3 real searches · 1 real-search pass
low-dose naltrexone fibromyalgia randomized controlled trials 2024 2025 systematic review guideline consensusGoogle ↗
OBSERVED
low-dose naltrexone myalgic encephalomyelitis chronic fatigue syndrome evidence protocol clinical trial reviewGoogle ↗
OBSERVED
low dose naltrexone fibromyalgia 2024 trial 6 mg placebo randomized crossoverGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
low-dose naltrexone fibromyalgia randomized controlled trials 2024 2025 systematic review guideline consensus Google ↗
low-dose naltrexone myalgic encephalomyelitis chronic fatigue syndrome evidence protocol clinical trial review Google ↗
low dose naltrexone fibromyalgia 2024 trial 6 mg placebo randomized crossover Google ↗
- Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial · pubmed.ncbi.nlm.nih.gov
- Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial · sciencedirect.com
- Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis · pubmed.ncbi.nlm.nih.gov
- Efficacy of Low-Dose Naltrexone in Treating Patients with Fibromyalgia: systematic Review and Meta-Analysis · pubmed.ncbi.nlm.nih.gov
- Efficacy and safety of low-dose naltrexone (LDN) in fibromyalgia: a systematic review and meta-analysis · pmc.ncbi.nlm.nih.gov
- Review of fibromyalgia treatment guidelines: part 2 – pharmacological treatment | Advances in Rheumatology · link.springer.com
- Review of fibromyalgia treatment guidelines: part 2 – pharmacological treatment · pmc.ncbi.nlm.nih.gov
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management · pmc.ncbi.nlm.nih.gov
- Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Updated Systematic Evidence Review · stacks.cdc.gov
- Evaluating the Therapeutic Benefits of Naltrexone in ME/CFS and Long Covid Patients: A Systematic Literature Review (P9-2.002) · neurology.org
- Low-dose Naltrexone Improves post-COVID-19 condition Symptoms. · pubmed.ncbi.nlm.nih.gov
- Pyridostigmine and low-dose naltrexone for ME/CFS: study protocol for the Life Improvement Trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial | Trials · link.springer.com
- Recommendations | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance · nice.org.uk
- Monitoring the Use of Medicines and Supplements | ME/CFS · cdc.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
low-dose naltrexone fibromyalgia randomized controlled trials 2024 2025 systematic review guideline consensus OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
low-dose naltrexone myalgic encephalomyelitis chronic fatigue syndrome evidence protocol clinical trial review OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
low dose naltrexone fibromyalgia 2024 trial 6 mg placebo randomized crossover OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |